Apellis Pharmaceuticals buy phonebroker
Start price
18.01.18
/
50%
€17.99
Target price
22.01.18
€18.94
Performance (%)
6.26%
End price
22.01.18
€19.11
Summary
This prediction ended on 22.01.18 with a price of €19.11. With a performance of 6.26%, the BUY prediction by phonebroker for Apellis Pharmaceuticals closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% | 56.827% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% | 83.028% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% | 50.695% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% | 57.560% |
Comments by phonebroker for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Ein Zock
(Zielkurs erreicht)


